{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:21:02Z","timestamp":1757452862854},"posted":{"date-parts":[[2023,8,22]]},"group-title":"In Review","reference-count":51,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,8,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p><jats:bold>Background<\/jats:bold>: Common neuropathologies associated with dementia include Alzheimer\u2019s disease neuropathologic change (ADNC) and limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC). Biofluid proteomics provides a window into the pathobiology of dementia and the information from biofluid tests may help guide clinical management. \n<jats:bold>Methods<\/jats:bold>: Participants were recruited from a longitudinal cohort of older adults at the University of Kentucky AD Research Center. A convenience sample of clinically obtained lumbar puncture cerebrospinal fluid (CSF) samples was analyzed from 29 older adults that had autopsy confirmation of the presence or absence of LATE-NC. Nine of the participants had autopsy-confirmed LATE-NC. Antemortem CSF specimens were analyzed in two separate processes: From one group, aliquots were depleted of highly abundant proteins using affinity spin columns. Tryptic digests of sample proteins were subjected to liquid chromatographic separation and mass spectrometry using an Eksigent Ekspert nanoLC 400 system in line with a Sciex 6600+ mass spectrometer. Protein identification was performed using Protein Pilot (Sciex, ver. 5) software, and relative quantification was performed using the SWATH processing microApp in PeakView and MarkerView software (Sciex), respectively. Following data analyses, additional studies were performed using western blots. \n<jats:bold>Results<\/jats:bold>: A total of 830 proteins were identified in the samples depleted of abundant proteins, and 730 proteins were identified in the non-depleted samples. Whereas some dementia-related proteins were detected (A\u03b2 peptide and \u03b1-synuclein protein), others were not (TDP-43, TMEM106B, and tau proteins). When the Bonferroni correction was applied to correct for multiple comparisons, only 4 proteins showed differential expression (LATE-NC vs non-LATE-NC) in the nondepleted samples (RBP4, MIF, IGHG3 and ITM2B), whereas none showed statistically different changes in the depleted samples. Post-hoc western blots confirmed that RBP4 expression was higher in the LATE-NC cases at the group level, but there was overlap between the levels of RBP4 in LATE-NC and non-LATE-NC cases. \n<jats:bold>Conclusions<\/jats:bold>: An exploratory assessment of CSF proteomes of autopsy-confirmed LATE-NC and non-LATE-NC cases from a community-based cohort failed to demonstrate a clear-cut proteomic fingerprint that distinguished the two groups. There was intriguing increase in RBP4 protein levels in CSF from LATE-NC cases. This may provide clues about pathogenetic mechanisms in LATE-NC.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3252238\/v1","type":"posted-content","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T20:44:23Z","timestamp":1692737063000},"source":"Crossref","is-referenced-by-count":3,"title":["Exploratory mass spectrometry of cerebrospinal fluid from persons with autopsy-confirmed LATE-NC"],"prefix":"10.21203","author":[{"given":"Jozsef","family":"Gal","sequence":"first","affiliation":[{"name":"University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin","family":"Vary","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Gartner","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Jicha","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin L.","family":"Abner","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulica S.","family":"Ortega","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Choucair","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna M.","family":"Wilcock","sequence":"additional","affiliation":[{"name":"Indiana University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Nelson","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nelson","sequence":"additional","affiliation":[{"name":"University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a","volume":"123","author":"Montine TJ","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a. practical approach Acta Neuropathol. 2012;123:1\u201311. 10.1007\/s00401-011-0910-3.","journal-title":"practical approach Acta Neuropathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz099","author":"Nelson PT","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K et al. (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report Brain 142, 1503\u20131527 10.1093\/brain\/awz099."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","article-title":"Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study","volume":"141","author":"Attems J","year":"2021","unstructured":"Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G, et al. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol. 2021;141:159\u201372. 10.1007\/s00401-020-02255-2.","journal-title":"Acta Neuropathol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/brain\/awab092","article-title":"To what degree is late life cognitive decline driven by age-relatedneuropathologies?","volume":"144","author":"Boyle PA","year":"2021","unstructured":"Boyle PA, Wang T, Yu L, Wilson RS, Dawe R, Arfanakis K, et al. To what degree is late life cognitive decline driven by age-relatedneuropathologies? Brain. 2021;144:2166\u201375. 10.1093\/brain\/awab092.","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz099","author":"Nelson PT","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K et al. (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report Brain 142, 1503\u20131527 10.1093\/brain\/awz099."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/brain\/awab092","article-title":"To what degree is late life cognitive decline driven by age-related neuropathologies?","volume":"144","author":"Boyle PA","year":"2021","unstructured":"Boyle PA, Wang T, Yu L, Wilson RS, Dawe R, Arfanakis K, et al. To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021;144:2166\u201375. 10.1093\/brain\/awab092.","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1126\/science.1134108","author":"Neumann M","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314, 130\u2013133 314\/5796\/130\/10.1126\/science.1134108."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41374-019-0196-y","article-title":"Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy Lab Invest","volume":"99","author":"Chornenkyy Y","year":"2019","unstructured":"Chornenkyy Y, Fardo DW, andNelson PT. (2019) Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy Lab Invest 99, 993\u20131007 10.1038\/s41374-019-0196-y."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40478-018-0531-3","article-title":"TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease","volume":"6","author":"Nag S","year":"2018","unstructured":"Nag S, Yu L, Boyle PA, Leurgans SE, Bennett DA, andSchneider JA. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. Acta Neuropathol Commun. 2018;6:33. 10.1186\/s40478-018-0531-3.","journal-title":"Acta Neuropathol Commun"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-022-02416-5","author":"Cykowski MD","year":"2022","unstructured":"Cykowski MD, Arumanayagam AS, Powell SZ, Rivera AL, Abner EL, Roman GC et al. (2022) Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies Acta Neuropathol 10.1007\/s00401-022-02416-5."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12365","author":"Winston CN","year":"2022","unstructured":"Winston CN, Sukreet S, Lynch H, Lee VM, Wilcock DM, Nelson PT et al. (2022) Evaluation of blood-based, extracellular vesicles as biomarkers for aging-related TDP-43 pathology Alzheimers Dement (Amst) 14, e12365 10.1002\/dad2.12365."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12939","author":"Agrawal S","year":"2021","unstructured":"Agrawal S, Yu L, Kapasi A, James BD, Arfanakis K, Barnes LL et al. (2021) Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons Brain Pathol e12939 10.1111\/bpa.12939."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e1422","DOI":"10.1212\/WNL.0000000000200001","article-title":"Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid","volume":"98","author":"Gauthreaux KM","year":"2022","unstructured":"Gauthreaux KM, Teylan MA, Katsumata Y, Mock C, Culhane JE, Chen YC, et al. Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid. Hippocampal Scler Neurol. 2022;98:e1422\u201333. 10.1212\/WNL.0000000000200001.","journal-title":"Hippocampal Scler Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-021-02360-w","author":"Harrison WT","year":"2021","unstructured":"Harrison WT, Lusk JB, Liu B, Ervin JF, Johnson KG, Green CL et al. (2021) Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is independently associated with dementia and strongly associated with arteriolosclerosis in the oldest-old Acta Neuropathol 10.1007\/s00401-021-02360-w."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt318","author":"Neltner JH","year":"2014","unstructured":"Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA et al. (2014) Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing Brain 137, 255\u2013267 10.1093\/brain\/awt318."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00401-023-02580-2","article-title":"Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology Acta Neuropathol","volume":"146","author":"Neumann M","year":"2023","unstructured":"Neumann M, Perneel J, Cheung S, Van den Broeck M, Nygaard H, Hsiung GR et al. (2023) Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology Acta Neuropathol 146, 163\u20136 10.1007\/s00401-023-02580-2."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3233\/JAD-230425","article-title":"Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes","volume":"94","author":"Di J","year":"2023","unstructured":"Di J, Nelson RS, Jicha GA, Moga DC, Barber JM, Cykowski MD, et al. Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes. J Alzheimers Dis. 2023;94:333\u201346. 10.3233\/JAD-230425.","journal-title":"J Alzheimers Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2174\/156720512801322591","article-title":"University of Kentucky Sanders-Brown Healthy Brain Aging Volunteers: Donor Characteristics, Procedures, and Neuropathology","volume":"9","author":"Schmitt FA","year":"2012","unstructured":"Schmitt FA, Nelson PT, Abner E, Scheff S, Jicha GA, Smith C, et al. University of Kentucky Sanders-Brown Healthy Brain Aging Volunteers: Donor Characteristics, Procedures, and Neuropathology. Curr Alzheimer Res. 2012;9:724\u201333. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22471862.","journal-title":"Curr Alzheimer Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01576-z","article-title":"Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort","volume":"11","author":"Nelson RS","year":"2023","unstructured":"Nelson RS, Abner EL, Jicha GA, Schmitt FA, Di J, Wilcock DM, et al. Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort. Acta Neuropathol Commun. 2023;11. 89 10.1186\/s40478-023-01576-z.","journal-title":"Acta Neuropathol Commun"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","article-title":"Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips","volume":"2","author":"Rappsilber J","year":"2007","unstructured":"Rappsilber J, Mann M, andIshihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2007;2:1896\u2013906. 10.1038\/nprot.2007.261.","journal-title":"Nat Protoc"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"856298","DOI":"10.3389\/fphys.2022.856298","article-title":"Adipokine Retinol Binding Protein 4 and Cardiovascular Diseases Front Physiol","volume":"13","author":"Ji Y","year":"2022","unstructured":"Ji Y, Song J, Su T, andGu X. (2022) Adipokine Retinol Binding Protein 4 and Cardiovascular Diseases Front Physiol 13, 856298 10.3389\/fphys.2022.856298."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1586\/14737159.8.3.289","article-title":"Retinol-binding protein-4 in experimental and clinical metabolic disease","volume":"8","author":"Eynatten M","year":"2008","unstructured":"von Eynatten M, andHumpert PM. Retinol-binding protein-4 in experimental and clinical metabolic disease. Expert Rev Mol Diagn. 2008;8:289\u201399. 10.1586\/14737159.8.3.289.","journal-title":"Expert Rev Mol Diagn"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12760","article-title":"Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review)","volume":"26","author":"Flores-Cortez YA","year":"2022","unstructured":"Flores-Cortez YA, Barragan-Bonilla MI, Mendoza-Bello JM, Gonzalez-Calixto C, Flores-Alfaro E, andEspinoza-Rojo M. Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review). Mol Med Rep. 2022;26. 10.3892\/mmr.2022.12760.","journal-title":"Mol Med Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3055712","author":"Liu C","year":"2022","unstructured":"Liu C, Gu J, Yao Y, Guo P, andHu H. (2022) Correlation between Retinol Binding Protein 4 and CT Perfusion Imaging and Prognosis in Patients with Acute Ischemic Stroke Based on Cell Imaging Data Analysis Contrast Media Mol Imaging 2022, 3055712 10.1155\/2022\/3055712."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/neu.2007.0386","article-title":"Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure","volume":"25","author":"Hergenroeder G","year":"2008","unstructured":"Hergenroeder G, Redell JB, Moore AN, Dubinsky WP, Funk RT, Crommett J, et al. Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. J Neurotrauma. 2008;25:79\u201393. 10.1089\/neu.2007.0386.","journal-title":"J Neurotrauma"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12640-018-9933-z","article-title":"Retinol-Binding Protein 4 Predicts Lesion Volume (Determined by MRI) and Severity of Acute Ischemic","volume":"35","author":"Liu C","year":"2019","unstructured":"Liu C, andChe Y. Retinol-Binding Protein 4 Predicts Lesion Volume (Determined by MRI) and Severity of Acute Ischemic. Stroke Neurotox Res. 2019;35:92\u20139. 10.1007\/s12640-018-9933-z.","journal-title":"Stroke Neurotox Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2174\/1567202618666211122150730","article-title":"Plasma Retinol Binding Protein 4 as a Biomarker for Detecting Progressive Stroke and Prediction of Early Prognosis in Patients with Acute Ischemic Stroke","volume":"18","author":"Liu S","year":"2021","unstructured":"Liu S, Li J, Rong X, Wei Y, Peng Y, andShen Q. Plasma Retinol Binding Protein 4 as a Biomarker for Detecting Progressive Stroke and Prediction of Early Prognosis in Patients with Acute Ischemic Stroke. Curr Neurovasc Res. 2021;18:381\u20138. 10.2174\/1567202618666211122150730.","journal-title":"Curr Neurovasc Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/jnc.13419","article-title":"Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage","volume":"136","author":"Llombart V","year":"2016","unstructured":"Llombart V, Garcia-Berrocoso T, Bustamante A, Giralt D, Rodriguez-Luna D, Muchada M, et al. Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage. J Neurochem. 2016;136:416\u201324. 10.1111\/jnc.13419.","journal-title":"J Neurochem"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.08.003","article-title":"Plasma Retinol-Binding Protein 4 Levels and the Risk of Ischemic Stroke among Women","volume":"27","author":"Rist PM","year":"2018","unstructured":"Rist PM, Jimenez MC, Tworoger SS, Hu FB, Manson JE, Sun Q, et al. Plasma Retinol-Binding Protein 4 Levels and the Risk of Ischemic Stroke among Women. J Stroke Cerebrovasc Dis. 2018;27:68\u201375. 10.1016\/j.jstrokecerebrovasdis.2017.08.003.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180786","article-title":"Evaluation of serum retinol-binding protein-4 levels as a biomarker of poor short-term prognosis in ischemic stroke","volume":"38","author":"Zhu YY","year":"2018","unstructured":"Zhu YY, Zhang JL, Liu L, Han Y, Ge X, andZhao S. Evaluation of serum retinol-binding protein-4 levels as a biomarker of poor short-term prognosis in ischemic stroke. Biosci Rep. 2018;38. 10.1042\/BSR20180786.","journal-title":"Biosci Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e2239","DOI":"10.1210\/clinem\/dgaa983","article-title":"Systematic Quantification of Neurotrophic Adipokines RBP4, PEDF, and Clusterin in Human Cerebrospinal Fluid and Serum","volume":"106","author":"Hopfinger A","year":"2021","unstructured":"Hopfinger A, Berghoff M, Karrasch T, Schmid A, andSchaffler A. Systematic Quantification of Neurotrophic Adipokines RBP4, PEDF, and Clusterin in Human Cerebrospinal Fluid and Serum. J Clin Endocrinol Metab. 2021;106:e2239\u201350. 10.1210\/clinem\/dgaa983.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/JAD-180682","article-title":"Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia","volume":"67","author":"Ishii M","year":"2019","unstructured":"Ishii M, Kamel H, andIadecola C. Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia. J Alzheimers Dis. 2019;67:257\u201363. 10.3233\/JAD-180682.","journal-title":"J Alzheimers Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.7754382","article-title":"Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein Science","volume":"268","author":"Monaco HL","year":"1995","unstructured":"Monaco HL, Rizzi M, andCoda A. (1995) Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein Science 268, 1039\u201341 10.1126\/science.7754382."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1021\/bi982291i","article-title":"The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP Biochemistry","volume":"38","author":"Naylor HM","year":"1999","unstructured":"Naylor HM, andNewcomer ME. (1999) The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP Biochemistry 38, 2647\u201353 10.1021\/bi982291i."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.1111\/j.1742-4658.2008.06705.x","article-title":"Structural and mutational analyses of protein-protein interactions between transthyretin and retinol-binding protein","volume":"275","author":"Zanotti G","year":"2008","unstructured":"Zanotti G, Folli C, Cendron L, Alfieri B, Nishida SK, Gliubich F, et al. Structural and mutational analyses of protein-protein interactions between transthyretin and retinol-binding protein. FEBS J. 2008;275:5841\u201354. 10.1111\/j.1742-4658.2008.06705.x.","journal-title":"FEBS J"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1515\/bmc-2013-0038","article-title":"Transthyretin: a multifaceted protein Biomol Concepts","volume":"5","author":"Vieira M","year":"2014","unstructured":"Vieira M, andSaraiva MJ. (2014) Transthyretin: a multifaceted protein Biomol Concepts 5, 45\u201354 10.1515\/bmc-2013-0038."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nature22366","article-title":"Architecture of the human interactome defines protein communities and disease networks","volume":"545","author":"Huttlin EL","year":"2017","unstructured":"Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, et al. Architecture of the human interactome defines protein communities and disease networks. Nature. 2017;545:505\u20139. 10.1038\/nature22366.","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.011","author":"Huttlin EL","year":"2021","unstructured":"Huttlin EL, Bruckner RJ, Navarrete-Perea J, Cannon JR, Baltier K, Gebreab F et al. (2021) Dual proteome-scale networks reveal cell-specific remodeling of the human interactome Cell 184, 3022\u20133040 e3028 10.1016\/j.cell.2021.04.011."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7760","author":"Ayton S","year":"2015","unstructured":"Ayton S, Faux NG, Bush AI, andAlzheimer's Disease Neuroimaging. I. (2015) Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE Nat Commun 6, 6760 10.1038\/ncomms7760."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/biot.200800247","article-title":"BRI2 as a central protein involved in neurodegeneration Biotechnol","volume":"3","author":"Tsachaki M","year":"2008","unstructured":"Tsachaki M, Ghiso J, andEfthimiopoulos S. (2008) BRI2 as a central protein involved in neurodegeneration Biotechnol J 3, 1548\u201354 10.1002\/biot.200800247."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JAD-131364","article-title":"Role of BRI2 in dementia","volume":"40","author":"Campo M","year":"2014","unstructured":"Del Campo M, andTeunissen CE. Role of BRI2 in dementia. J Alzheimers Dis. 2014;40:481\u201394. 10.3233\/JAD-131364.","journal-title":"J Alzheimers Dis"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.1007\/s00018-021-03932-5","article-title":"The role of the integral type II transmembrane protein BRI2 in health and disease","volume":"78","author":"Martins F","year":"2021","unstructured":"Martins F, Santos I, da Cruz ESOAB, Tambaro S, andRebelo S. The role of the integral type II transmembrane protein BRI2 in health and disease. Cell Mol Life Sci. 2021;78:6807\u201322. 10.1007\/s00018-021-03932-5.","journal-title":"Cell Mol Life Sci"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00795-018-0191-1","article-title":"BRI2 as an anti-Alzheimer gene","volume":"52","author":"Matsuda S","year":"2019","unstructured":"Matsuda S, andSenda T. BRI2 as an anti-Alzheimer gene. Med Mol Morphol. 2019;52:1\u20137. 10.1007\/s00795-018-0191-1.","journal-title":"Med Mol Morphol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"15815","DOI":"10.1074\/jbc.M109.006403","article-title":"BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2","volume":"284","author":"Matsuda S","year":"2009","unstructured":"Matsuda S, Matsuda Y, andD'Adamio L. BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2. J Biol Chem. 2009;284:15815\u201325. 10.1074\/jbc.M109.006403.","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"37446","DOI":"10.1074\/jbc.M111.288373","article-title":"BRI2 protein regulates beta-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE)","volume":"286","author":"Kilger E","year":"2011","unstructured":"Kilger E, Buehler A, Woelfing H, Kumar S, Kaeser SA, Nagarathinam A, et al. BRI2 protein regulates beta-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE). J Biol Chem. 2011;286:37446\u201357. 10.1074\/jbc.M111.288373.","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/14783","article-title":"Furin mediates enhanced production of fibrillogenic ABri peptides in familial British","volume":"2","author":"Kim SH","year":"1999","unstructured":"Kim SH, Wang R, Gordon DJ, Bass J, Steiner DF, Lynn DG, et al. Furin mediates enhanced production of fibrillogenic ABri peptides in familial British. Dement Nat Neurosci. 1999;2:984\u20138. 10.1038\/14783.","journal-title":"Dement Nat Neurosci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/21637","article-title":"A stop-codon mutation in the BRI gene associated with familial","volume":"399","author":"Vidal R","year":"1999","unstructured":"Vidal R, Frangione B, Rostagno A, Mead S, Revesz T, Plant G, et al. A stop-codon mutation in the BRI gene associated with familial. Br Dement Nat. 1999;399:776\u201381. 10.1038\/21637.","journal-title":"Br Dement Nat"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1749-6632.2000.tb06908.x","article-title":"Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13","volume":"920","author":"Ghiso J","year":"2000","unstructured":"Ghiso J, Vidal R, Rostagno A, Miravalle L, Holton JL, Mead S, et al. Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13. Ann N Y Acad Sci. 2000;920:84\u201392. 10.1111\/j.1749-6632.2000.tb06908.x.","journal-title":"Ann N Y Acad Sci"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1749-6632.2000.tb06909.x","article-title":"Familial British dementia: expression and metabolism of BRI Ann N","volume":"920","author":"Kim SH","year":"2000","unstructured":"Kim SH, Wang R, Gordon DJ, Bass J, Steiner DF, Thinakaran G, et al. Familial British dementia: expression and metabolism of BRI Ann N. Y Acad Sci. 2000;920:93\u20139. 10.1111\/j.1749-6632.2000.tb06909.x.","journal-title":"Y Acad Sci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad193","author":"Banerjee G","year":"2023","unstructured":"Banerjee G, Collinge J, Fox NC, Lashley T, Mead S, Schott JM et al. (2023) Clinical considerations in early-onset cerebral amyloid angiopathy Brain 10.1093\/brain\/awad193."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/prca.200600999","article-title":"Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease","volume":"1","author":"Hu Y","year":"2007","unstructured":"Hu Y, Hosseini A, Kauwe JS, Gross J, Cairns NJ, Goate AM, et al. Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease. Proteom Clin Appl. 2007;1:1373\u201384. 10.1002\/prca.200600999.","journal-title":"Proteom Clin Appl"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3252238\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3252238\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T13:46:54Z","timestamp":1700056014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3252238\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":51,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3252238\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,8,22]]},"subtype":"preprint"}}